AMSTERDAM/SAO PAULO– Leader Biomedical is proud to announce that our manufacturing facility in Nijmegen, European Medical Contract Manufacturing B.V. (EMCM) has received approval by the…
Urogyn B.V. and Leader Biomedical are proud to announce that Urolastic™ – an innovative Urinary Stress incontinence product – has been introduced into the product…
Leader Biomedical Group further increases its global footprint by establishing Leader Biomedical ASIA PACIFIC SDN.BHD., in Selangor, Malaysia (Leader Biomedical APAC). Leader Biomedical APAC will…
Leader Biomedical Group is further expanding its footprint into Russia with the establishment of Leader Biomedical RUS, LLC, in Moscow. This is yet another important…
Amsterdam | 24 June 2016 | It is with great pleasure that we announce the change in location of the Leader Biomedical Europe, Amsterdam office.…
HONG KONG and AMSTERDAM: To better meet the need for biocompatible grafts with good osteoconductive properties, Leader Biomedical has launched the OssGro® range of synthetic…
Leader Biomedical Group has forged an equity alliance with BioTiss GmbH, which will consolidate human musculoskeletal tissue processing at their facilities in Austria. The alliance…
Leo Liyeung, Executive Director Leader Biomedical Group, met with King Willem-Alexander during his state visit to China in October 2015. Mr Liyeung met the Dutch…
Leader Biomedical Group has expanded its global footprint into South America with the establishment of Inovações Biológicas Comercial LTDA. Based in São Paulo, the company’s…
European Medical Contract Manufacturing BV, a Leader Biomedical Group company, has received regulatory approval from Swissmedic to place its range of eTiss® human allografts for…